These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 19538209)

  • 1. BDNF Val66Met polymorphism is associated with cognitive impairment in Italian patients with Parkinson's disease.
    Guerini FR; Beghi E; Riboldazzi G; Zangaglia R; Pianezzola C; Bono G; Casali C; Di Lorenzo C; Agliardi C; Nappi G; Clerici M; Martignoni E
    Eur J Neurol; 2009 Nov; 16(11):1240-5. PubMed ID: 19538209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BDNF G196A (Val66Met) polymorphism associated with cognitive impairment in Parkinson's disease.
    Białecka M; Kurzawski M; Roszmann A; Robowski P; Sitek EJ; Honczarenko K; Mak M; Deptuła-Jarosz M; Gołąb-Janowska M; Droździk M; Sławek J
    Neurosci Lett; 2014 Feb; 561():86-90. PubMed ID: 24394906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of brain-derived neurotrophic factor (BDNF) Val66Met polymorphism with Parkinson's disease in a Greek population.
    Karakasis C; Kalinderi K; Katsarou Z; Fidani L; Bostantjopoulou S
    J Clin Neurosci; 2011 Dec; 18(12):1744-5. PubMed ID: 22001244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between brain-derived neurotrophic factor (BDNF) gene polymorphisms and executive function in Japanese patients with Alzheimer's disease.
    Nagata T; Shinagawa S; Nukariya K; Ochiai Y; Kawamura S; Agawa-Ohta M; Kasahara H; Nakayama K; Yamada H
    Psychogeriatrics; 2011 Sep; 11(3):141-9. PubMed ID: 21951954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No association between brain-derived neurotrophic factor G196A polymorphism and clinical features of Parkinson's disease.
    Svetel M; Pekmezovic T; Markovic V; Novaković I; Dobričić V; Djuric G; Stefanova E; Kostić V
    Eur Neurol; 2013; 70(5-6):257-62. PubMed ID: 24051673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Val66Met BDNF polymorphism is associated with Parkinson's disease cognitive impairment.
    Altmann V; Schumacher-Schuh AF; Rieck M; Callegari-Jacques SM; Rieder CR; Hutz MH
    Neurosci Lett; 2016 Feb; 615():88-91. PubMed ID: 26806863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain-derived neurotrophic factor G196A polymorphism and clinical features in Parkinson's disease.
    Gao L; Díaz-Corrales FJ; Carrillo F; Díaz-Martín J; Caceres-Redondo MT; Carballo M; Palomino A; López-Barneo J; Mir P
    Acta Neurol Scand; 2010 Jul; 122(1):41-5. PubMed ID: 20085561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effects of BDNF Val66Met Gene Polymorphism on Serum BDNF and Cognitive Function in Methamphetamine-Dependent Patients and Normal Controls: A Case-Control Study.
    Su H; Tao J; Zhang J; Xie Y; Wang Y; Zhang Y; Han B; Lu Y; Sun H; Wei Y; Zou S; Wu W; Zhang J; Xu K; Zhang X; He J
    J Clin Psychopharmacol; 2015 Oct; 35(5):517-24. PubMed ID: 26280836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pattern of cortical thinning associated with the BDNF Val66Met polymorphism in Parkinson's disease.
    Sampedro F; Marín-Lahoz J; Martínez-Horta S; Pagonabarraga J; Kulisevsky J
    Behav Brain Res; 2019 Oct; 372():112039. PubMed ID: 31202861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variations in the BDNF gene in autopsy-confirmed Alzheimer's disease and dementia with Lewy bodies in Japan.
    Akatsu H; Yamagata HD; Kawamata J; Kamino K; Takeda M; Yamamoto T; Miki T; Tooyama I; Shimohama S; Kosaka K
    Dement Geriatr Cogn Disord; 2006; 22(3):216-22. PubMed ID: 16899999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cognitive function, serum BDNF levels and BDNF gene Val66Met polymorphism in amnestic mild cognitive impairment].
    Yu H; Zhang ZJ; Shi YM; Bai F; Qian Y; Yuan YG; Deng LL
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Apr; 33(4):321-5. PubMed ID: 18460776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of a variation in the promoter region of the brain-derived neurotrophic factor gene with familial Parkinson's disease.
    Parsian A; Sinha R; Racette B; Zhao JH; Perlmutter JS
    Parkinsonism Relat Disord; 2004 Jun; 10(4):213-9. PubMed ID: 15120095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BDNF polymorphism associates with decline in set shifting in Parkinson's disease.
    van der Kolk NM; Speelman AD; van Nimwegen M; Kessels RP; IntHout J; Hakobjan M; Munneke M; Bloem BR; van de Warrenburg BP
    Neurobiol Aging; 2015 Mar; 36(3):1605.e1-6. PubMed ID: 25444596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A common polymorphism in the brain-derived neurotrophic factor gene in patients with adult-onset primary focal and segmental dystonia.
    Svetel MV; Djuric G; Novakovic I; Dobricic V; Stefanova E; Kresojevic N; Tomic A; Jankovic M; Petrovic I; Pekmezovic T; Kostic VS
    Acta Neurol Belg; 2013 Sep; 113(3):243-5. PubMed ID: 23381842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis study on the role of bone-derived neurotrophic factor Val66Met polymorphism in Parkinson's disease.
    Mariani S; Ventriglia M; Simonelli I; Bucossi S; Siotto M; R RS
    Rejuvenation Res; 2015 Feb; 18(1):40-7. PubMed ID: 25431370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The brain-derived neurotrophic factor (BDNF) Val66Met polymorphism is not significantly correlated to Transient Global Amnesia: preliminary results of an on-going study in Brescia Province, Italy.
    Agosti C; Borroni B; Archetti S; Akkawi NM; Padovani A
    Neurosci Lett; 2008 Oct; 443(3):228-31. PubMed ID: 18692116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between BDNF G196A (Val66Met) polymorphism and cognitive impairment in patients with Parkinson's disease: a meta-analysis.
    Wang Q; Liu J; Guo Y; Dong G; Zou W; Chen Z
    Braz J Med Biol Res; 2019; 52(8):e8443. PubMed ID: 31365694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene polymorphisms and motor levodopa-induced complications in Parkinson's disease.
    Michałowska M; Chalimoniuk M; Jówko E; Przybylska I; Langfort J; Toczylowska B; Krygowska-Wajs A; Fiszer U
    Brain Behav; 2020 Mar; 10(3):e01537. PubMed ID: 32022467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene.
    Rybakowski JK; Borkowska A; Skibinska M; Szczepankiewicz A; Kapelski P; Leszczynska-Rodziewicz A; Czerski PM; Hauser J
    Psychiatry Clin Neurosci; 2006 Feb; 60(1):70-6. PubMed ID: 16472361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphisms in Parkinson's disease and age of onset.
    Hong CJ; Liu HC; Liu TY; Lin CH; Cheng CY; Tsai SJ
    Neurosci Lett; 2003 Dec; 353(1):75-7. PubMed ID: 14642442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.